跳至主要内容
临床试验/NCT03797417
NCT03797417Unknown不适用

The Gut Microbiome and Metabolic Activity in Patients With Vitiligo

Xijing Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2018年9月18日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
Gut microbiota sequencing results by analyzing metagenomes of 16s rRNA gene or microbial genes

研究概览

简要总结

Vitiligo is a chronic depigmenting autoimmune-associated skin disease and a growing psychological health concern because of its low quality of life. Genetics, immunology and environment triggers contribute to the pathophysiology of vitiligo. Identify and decrease the risk factors of vitiligo is very crucial for vitiligo treatment and prevention. Emerging evidence has linked gut microbiome to human autoimmune diseases. Here the investigators will analyze 10,913 metagenomes in stool samples from 100 adult vitiligo patients and gut microbiome associated metabolites in patients serum.

详细描述

Vitiligo, an autoimmune disease of the skin, is a commonly acquired chronic depigmenting disorder characterized by loss of epidermal melanocytes and progressive depigmentation clinically, affecting from 0.5% to 1% of the world population and about 1% in China Vitiligo can be a psychologically crushing associated with low quality of life, especially in colored skinned individuals. The pathoetiology of vitiligo is multifactorial and has genetic, immunological, and environmental components. Several environment-associated mechanisms have been implicated to explain melanocyte disappearance, including ultraviolet (UV) radiation exposure, repeated mechanical or thermal stress, and exposure to chemicals (especially phenols or catechols), but epidemiologic data remain limited.

Broader gut dysbioses have been identified as potential causes or contributing factors to human autoimmune diseases; however, human studies have not yet identified microbial compositional or functional triggers that are predictive of skin autoimmunity or vitiligo. Metabolites from intestinal microbiota are key determinants of host-microbe mutualism and, consequently, the health or disease of the intestinal tract. However, whether such host-microbe crosstalk influences inflammation in peripheral tissues, such as the skin, is poorly understood.

The investigators will perform a metagenome association study and serum metabolomics profiling in a cohort of vitiligo Chinese individuals.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
3 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who volunteered and signed Informed Consent Form;
  • Male or female subjects 3-65 years of age;
  • Clinically confirmed the diagnosis of advanced vitiligo as per the diagnostic criteria for vitiligo specified in Clinical Dermatology;
  • Stable vital signs.

排除标准

  • Patients who had taken systemic or local treatment with vitiligo in the last month;
  • Patients who had taken systemic antibiotics,systemic hormones,cytokines, immunosuppressors in the previous three months;
  • The combination of other autoimmune diseases,gastrointestinal diseases, hepatic diseases, psychiatric and psycho-related diseases, or other skin diseases;
  • The combination of Serious, life-threatening condition such as cardiac diseases, renal diseases, endocrine system disease, cancer, or immunodeficiency diseases;
  • Women of child-bearing potential who are pregnant, plan to become pregnant during the study or are lactating;
  • Any other condition that the investigator deems unsuitable for entering the study.

结局指标

主要结局

Gut microbiota sequencing results by analyzing metagenomes of 16s rRNA gene or microbial genes

时间窗: 2018.10.1--2019.3.1

Fecal samples are obtained from all recruited subjects for metagenomic sequencing. The individuals have not received any antibiotic treatment for at least one month before sample collection. In the seven days before sample collection, subjects did not take any food containing probiotics such as yogurt. Each sample was either frozen immediately at -80 °C or briefly stored in personal -20 °C freezers before transport to the laboratory within 24 h. After extracting DNA from fecal samoles, gut microbiota sequencing results by using Shotgun Strategy or Meta 16s high-throughput sequencing.

Gut microbiota associated metabolic pathways by using metabolomics profiling of serum samples study

时间窗: 2018.12.1--2019.3.1

All serum samples will be thawed on ice and a quality control (QC) sample, made by mixing and blending equal volumes (10 μl) of each serum sample, is used to estimate a mean profile representing all the analytes encountered during analysis. The acquired MS data pretreatments included peak selection and grouping, retention time correction, second peak grouping, and isotopes and adducts annotation, will be performed as previously described56. LC-MS raw data files will be converted into mzXML format and then analyzed by the XCMS and CAMERA toolbox with R statistical language.

Vitiligo associated activity measurements like VASI assays, serum markers detection

时间窗: 2019.1--2019.3.1

VASI assays will be used to evaluate patients disease condition. VASI Scoring Criteria VASI=Σall body sites (hand units) × depigmentation. Serum markers like CXCL10, IL-2, and sCD25 will be detected by ELISA kits.

次要结局

未报告次要终点

研究者

发起方
Xijing Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Li Chunying-1

Vice Chief

Xijing Hospital

研究点 (1)

Loading locations...

相似试验

Gut Microbiome and Metabolic Pathways Changes in... | 临床试验